1 North Wealth Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.46K Hold
156
﹤0.01% 164
2025
Q4
$8.41K Hold
156
﹤0.01% 170
2025
Q3
$7.04K Hold
156
﹤0.01% 166
2025
Q2
$7.22K Hold
156
﹤0.01% 166
2025
Q1
$9.51K Buy
+156
New +$9.09K ﹤0.01% 150
2019
Q4
$55K Buy
850
+33
+4% +$1.89K 0.03% 85
2019
Q3
$41K Buy
+817
New +$38.4K 0.03% 78
2019
Q1
$39K Hold
817
0.03% 77
2018
Q4
$42K Buy
+817
New +$43.9K 0.04% 72

Other funds holding BMY

1 North Wealth Services's BMY Position: Q1 2026 in Review

1 North Wealth Services held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 156 shares worth $9.46K. The position accounts for ﹤0.01% of the portfolio, ranked #164.

1 North Wealth Services first reported a position in BMY in Q4 2018 and has held it in 9 quarters since. The position peaked at $55K in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • 1 North Wealth Services held 156 shares of Bristol-Myers Squibb worth $9.46K as of Q1 2026.
  • 1 North Wealth Services left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of 1 North Wealth Services's portfolio in Q1 2026, its #164 holding.
  • 1 North Wealth Services first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 9 quarters since.
  • 1 North Wealth Services's Bristol-Myers Squibb position peaked at $55K in Q4 2019.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on 1 North Wealth Services's 13F filing for Q1 2026, filed 4 May 2026.